Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Practices encouraged to speak to rabbit owners about RVHD2
rabbit
Vets should recommend rabbits are kept separate from any other rabbits they do not usually interact with.

Disease is now geographically widespread in the UK

Veterinary organisations have issued advice to practices on a new strain of Rabbit Viral Haemorrhagic Disease.

As the spread of RVHD2 may be facilitated by its apparent progression, compared to RVHD1, the BVA, BSAVA and BVZA recommend practices talk to owners about preventing this potentially devastating disease.

In a joint statement, they write: 'Due to recent media coverage of RVHD2, vets may be contacted by concerned owners seeking advice on how to prevent their rabbits contracting this disease.

'Further to vaccinating, vets should recommend rabbits are kept separate from any other rabbits they do not usually interact with; are prevented from having contact with wild rabbits and do not attend any rabbit shows unless already vaccinated.'

RVHD2 is more variable in its rate of disease progression than RVHD1, with presentation ranging from sudden death (with or without bleeding from the orifices) to a longer disease course of three to nine days. 

This longer disease course increases the risk of sick rabbits being brought into practices and, in turn, increases the risk of transmission to other pet rabbits.

Vaccines for the original strain of RVHD1 do not offer long term protection against RVHD2. However, vaccines for this new strain are now available in the UK. These can be purchased from Centaur, NVS and Henry Schein Animal Health.

John Chitty, BSAVA vice president, said: “BSAVA would encourage practices to talk to rabbit owning clients about RVHD2 vaccines, and where there is deemed sufficient risk recommend the vaccine along with the essential vaccination against Myxomatosis – and it should be noted that this must not be done within two weeks of vaccination against RVHD2.”

BVZS president Mark Stidworthy adds: “It is clear from post-mortem examinations and PCR testing over the last 18 months that RVHD2 is now geographically widespread in the UK and all rabbits should be considered at risk from this potentially devastating disease.”

Become a member or log in to add this story to your CPD history

RUMA CA&E extends survey deadline

News Story 1
 RUMA CA&E has extended the deadline for its online survey into vaccine availability.

Vets, SQPs, retailers and wholesalers will now have until Friday, 26 September at 5pm to submit their response.

The survey aims to further understanding into the vaccine supply challenges faced by the sector. It will also consider the short and long term impacts of disruption issues.

Insights are anonymous, and will be shared with industry stakeholders and government bodies.

The survey can be accessed here

Click here for more...
News Shorts
Dechra launches checklist for veterinary sustainability

Global animal health specialist Dechra has announced the world's first Veterinary Green Theatre Checklist (VGTC) to help make surgery more sustainable.

Endorsed by leading veterinary organisations, including the BEVA, BVNA and RCVS Knowledge, the checklist is designed to reduce the environmental footprint of veterinary care, while supporting better animal health outcomes.

The checklist was launched at the World Congress of Veterinary Anaesthesia and Analgesia in Paris and will be followed by an internal training and awareness campaign. For more information, visit dechra.com